
Humana Inc. (NYSE:HUM – Free Report) – Analysts at Zacks Research increased their Q1 2027 EPS estimates for Humana in a research note issued to investors on Tuesday, September 29th. Zacks Research analyst Team now expects that the insurance provider will post earnings of $9.13 per share for the quarter, up from their previous forecast of $9.04. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Humana’s current full-year earnings is $9.00 per share. Zacks Research also issued estimates for Humana’s Q2 2027 earnings at $5.30 EPS and Q2 2028 earnings at $6.69 EPS.
Other equities analysts also recently issued research reports about the company. Wolfe Research reiterated an “outperform” rating and set a $450.00 price target on shares of Humana in a report on Monday, August 24th. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Humana in a research note on Thursday, July 30th. They issued a “hold” rating for the company. Royal Bank Of Canada raised their target price on shares of Humana from $246.00 to $415.00 and gave the company a “sector perform” rating in a research note on Thursday, July 9th. Robert W. Baird set a $390.00 target price on shares of Humana in a research report on Thursday, July 30th. Finally, Barclays upgraded shares of Humana from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $407.00 to $515.00 in a report on Friday. Fifteen research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $408.61.
Humana Stock Performance
Shares of NYSE HUM opened at $386.55 on Wednesday. The business’s 50-day simple moving average is $386.00 and its 200-day simple moving average is $321.83. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. Humana has a 52 week low of $163.11 and a 52 week high of $428.88. The firm has a market cap of $46.42 billion, a price-to-earnings ratio of 36.57, a P/E/G ratio of 2.41 and a beta of 0.74.
Humana (NYSE:HUM – Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. During the same quarter in the previous year, the business earned $6.27 EPS. Humana’s quarterly revenue was up 26.2% compared to the same quarter last year.
Hedge Funds Weigh In On Humana
Several large investors have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in shares of Humana in the 2nd quarter worth approximately $4,138,160,000. Capital International Investors raised its stake in shares of Humana by 113.9% in the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after purchasing an additional 3,097,571 shares in the last quarter. Pzena Investment Management LLC lifted its position in Humana by 34.3% in the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after purchasing an additional 1,398,774 shares during the period. Bank of New York Mellon Corp boosted its stake in Humana by 21.9% during the fourth quarter. Bank of New York Mellon Corp now owns 2,094,570 shares of the insurance provider’s stock worth $536,482,000 after buying an additional 376,803 shares in the last quarter. Finally, Norges Bank acquired a new position in Humana in the fourth quarter worth about $456,632,000. Institutional investors and hedge funds own 92.38% of the company’s stock.
Humana Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Stockholders of record on Friday, October 30th will be issued a dividend of $0.8850 per share. The ex-dividend date is Friday, October 30th. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. Humana’s payout ratio is presently 33.49%.
About Humana
Humana Inc is a health and well-being company headquartered in Louisville, Kentucky. Founded in 1961, the company began as a nursing home operator before expanding into hospitals and health insurance. Today, Humana primarily provides health insurance products and healthcare services for older adults, individuals, military families and other members in the United States.
Humana’s insurance business offers Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid coverage in select markets.
Further Reading
- Five stocks we like better than Humana
- The Bull Case for Amprius Technologies Just Got Stronger
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
